Genome-wide in vivo CRISPR screens identify GATOR1 as a potent tumor suppressor in MYC-driven lymphomagenesis
RNA-seq (gene expression) · mouse · 35 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 35 samples: 6 conditions, mostly with about 6 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphomaNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE285351_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1203216 and SRA study SRP553956. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 35 samples.
How we read this: 6 replicated groups read from 35 sample titles; they account for 35 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8701165 Full Serum - Depdc5 KO - 1 Full Serum - Depdc5 KO
- GSM8701166 Full Serum - Depdc5 KO - 2 Full Serum - Depdc5 KO
- GSM8701167 Full Serum - Depdc5 KO - 3 Full Serum - Depdc5 KO
- GSM8701168 Full Serum - Depdc5 KO - 4 Full Serum - Depdc5 KO
- GSM8701169 Full Serum - Depdc5 KO - 5 Full Serum - Depdc5 KO
- GSM8701170 Full Serum - Depdc5 KO - 6 Full Serum - Depdc5 KO
- GSM8701171 Full Serum - Control - 1 Full Serum - Control
- GSM8701172 Full Serum - Control - 2 Full Serum - Control
- GSM8701173 Full Serum - Control - 3 Full Serum - Control
- GSM8701174 Full Serum - Control - 4 Full Serum - Control
- GSM8701175 Full Serum - Control - 5 Full Serum - Control
- GSM8701176 Full Serum - Nprl3 KO - 1 Full Serum - Nprl3 KO
- GSM8701177 Full Serum - Nprl3 KO - 2 Full Serum - Nprl3 KO
- GSM8701178 Full Serum - Nprl3 KO - 3 Full Serum - Nprl3 KO
- GSM8701179 Full Serum - Nprl3 KO - 4 Full Serum - Nprl3 KO
- GSM8701180 Full Serum - Nprl3 KO - 5 Full Serum - Nprl3 KO
- GSM8701181 Full Serum - Nprl3 KO - 6 Full Serum - Nprl3 KO
- GSM8701182 Serum Deprivation - Depdc5 KO - 1 Serum Deprivation - Dep…
- GSM8701183 Serum Deprivation - Depdc5 KO - 2 Serum Deprivation - Dep…
- GSM8701184 Serum Deprivation - Depdc5 KO - 3 Serum Deprivation - Dep…
- GSM8701185 Serum Deprivation - Depdc5 KO - 4 Serum Deprivation - Dep…
- GSM8701186 Serum Deprivation - Depdc5 KO - 5 Serum Deprivation - Dep…
- GSM8701187 Serum Deprivation - Depdc5 KO - 6 Serum Deprivation - Dep…
- GSM8701188 Serum Deprivation - Control - 1 Serum Deprivation - Con…
- GSM8701189 Serum Deprivation - Control - 2 Serum Deprivation - Con…
- GSM8701190 Serum Deprivation - Control - 3 Serum Deprivation - Con…
- GSM8701191 Serum Deprivation - Control - 4 Serum Deprivation - Con…
- GSM8701192 Serum Deprivation - Control - 5 Serum Deprivation - Con…
- GSM8701193 Serum Deprivation - Control - 6 Serum Deprivation - Con…
- GSM8701194 Serum Deprivation - Nprl3 KO - 1 Serum Deprivation - Npr…
- GSM8701195 Serum Deprivation - Nprl3 KO - 2 Serum Deprivation - Npr…
- GSM8701196 Serum Deprivation - Nprl3 KO - 3 Serum Deprivation - Npr…
- GSM8701197 Serum Deprivation - Nprl3 KO - 4 Serum Deprivation - Npr…
- GSM8701198 Serum Deprivation - Nprl3 KO - 5 Serum Deprivation - Npr…
- GSM8701199 Serum Deprivation - Nprl3 KO - 6 Serum Deprivation - Npr…
- GSE269463 Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma 21 samples shares crispr, genome-wide, screens
- GSE334845 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors [RNA-Seq] 86 samples shares crispr, screens
- GSE268045 StealTHY: enabling CRISPR-Cas9 screens in immunocompetent hosts to expose concealed metastatic regulators [paired-end] 70 samples shares crispr, screens
- GSE268044 StealTHY: enabling CRISPR-Cas9 screens in immunocompetent hosts to expose concealed metastatic regulators [single-end] 45 samples shares crispr, screens
- GSE269446 In vivo CRISPR screens in Head and Neck Cancer reveal that Uchl5 modulates extracellular matrix deposition to promote immune evasion 23 samples shares crispr, screens
- GSE220556 In vivo CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer 20 samples shares crispr, screens
- GSE338899 In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion 12 samples shares crispr, screens
- GSE249759 In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer 12 samples shares crispr, screens
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.